Show simple item record

dc.contributor.authorHalkett, Georgia
dc.contributor.authorShort, M.
dc.contributor.authorAoun, Samar
dc.contributor.authorJoseph, D.
dc.contributor.authorBydder, S.
dc.contributor.authorMeng, X.
dc.contributor.authorSpry, N.
dc.date.accessioned2018-02-06T06:15:18Z
dc.date.available2018-02-06T06:15:18Z
dc.date.created2018-02-06T05:49:45Z
dc.date.issued2017
dc.identifier.citationHalkett, G. and Short, M. and Aoun, S. and Joseph, D. and Bydder, S. and Meng, X. and Spry, N. 2017. What pelvic radiation disease symptoms are experienced by patients receiving external beam radiotherapy and a high-dose-rate brachytherapy boost for prostate cancer?. Journal of Contemporary Brachytherapy. 9 (5): pp. 393-402.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/63117
dc.identifier.doi10.5114/jcb.2017.70731
dc.description.abstract

Purpose: Research describing proctitis or pelvic radiation disease symptoms of prostate cancer patients one year after external beam radiotherapy (EBRT) plus high-dose-rate (HDR) brachytherapy is limited. This study aimed to assess prostate cancer patients' pelvic radiation disease symptoms from baseline to 12 months post-radiotherapy. Material and methods: Men with prostate cancer referred for EBRT and HDR brachytherapy were recruited. Patients' age, diagnosis, staging, PSA, past medical history, and treatment were recorded. Pelvic radiation disease symptoms were assessed via the Phase III EORTC proctitis module. Patients completed questionnaires before radiotherapy (baseline) and at one, three, six, and 12 months afterwards. To assess acute toxicity, symptoms one month after radiotherapy were compared with baseline. To assess post-treatment recovery, symptoms at three, six, and 12 months post radiotherapy were compared with one month. Symptom changes over time were assessed with linear mixed effect models. Results: Two hundred and sixty-six patients were recruited. Mean scores were below 2 at all time-points. The proportion of patients experiencing symptoms were also calculated. Linear mixed effect models showed that time-point, age, and T-stage were associated with some pelvic radiation disease symptoms. Conclusions: Patients receiving EBRT plus HDR brachytherapy to the prostate experienced mild pelvic radiation disease symptoms. Determining the proportion of patients w ith symptoms provided the most meaningful data.

dc.titleWhat pelvic radiation disease symptoms are experienced by patients receiving external beam radiotherapy and a high-dose-rate brachytherapy boost for prostate cancer?
dc.typeJournal Article
dcterms.source.volume9
dcterms.source.number5
dcterms.source.startPage393
dcterms.source.endPage402
dcterms.source.issn1689-832X
dcterms.source.titleJournal of Contemporary Brachytherapy
curtin.departmentSchool of Nursing, Midwifery and Paramedicine
curtin.accessStatusOpen access via publisher


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record